nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—RALBP1—Vincristine—colon cancer	0.281	0.472	CbGbCtD
Carbamazepine—ABCB1—colon cancer	0.228	1	CbGaD
Carbamazepine—ABCC2—Irinotecan—colon cancer	0.0337	0.0567	CbGbCtD
Carbamazepine—ABCC2—Vincristine—colon cancer	0.0295	0.0495	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0225	0.0378	CbGbCtD
Carbamazepine—CYP3A7—Irinotecan—colon cancer	0.0225	0.0378	CbGbCtD
Carbamazepine—CYP2B6—Irinotecan—colon cancer	0.0214	0.036	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0197	0.0331	CbGbCtD
Carbamazepine—CYP3A7—Vincristine—colon cancer	0.0197	0.0331	CbGbCtD
Carbamazepine—CYP2C9—Capecitabine—colon cancer	0.0183	0.0308	CbGbCtD
Carbamazepine—ABCC2—Methotrexate—colon cancer	0.0178	0.03	CbGbCtD
Carbamazepine—CYP3A5—Irinotecan—colon cancer	0.0169	0.0284	CbGbCtD
Carbamazepine—CYP2C8—Fluorouracil—colon cancer	0.0156	0.0262	CbGbCtD
Carbamazepine—CYP3A5—Vincristine—colon cancer	0.0148	0.0248	CbGbCtD
Carbamazepine—CYP1A2—Fluorouracil—colon cancer	0.0121	0.0203	CbGbCtD
Carbamazepine—ABCB1—Irinotecan—colon cancer	0.011	0.0185	CbGbCtD
Carbamazepine—CYP2C9—Fluorouracil—colon cancer	0.0109	0.0183	CbGbCtD
Carbamazepine—ABCB1—Vincristine—colon cancer	0.00961	0.0161	CbGbCtD
Carbamazepine—CYP3A4—Irinotecan—colon cancer	0.00659	0.0111	CbGbCtD
Carbamazepine—ABCB1—Methotrexate—colon cancer	0.00582	0.00978	CbGbCtD
Carbamazepine—CYP3A4—Vincristine—colon cancer	0.00576	0.00968	CbGbCtD
Carbamazepine—ABCC2—bile—colon cancer	0.00425	0.157	CbGeAlD
Carbamazepine—RALBP1—smooth muscle tissue—colon cancer	0.0011	0.0406	CbGeAlD
Carbamazepine—UGT2B7—renal system—colon cancer	0.00106	0.039	CbGeAlD
Carbamazepine—RALBP1—renal system—colon cancer	0.00106	0.039	CbGeAlD
Carbamazepine—SCN4A—renal system—colon cancer	0.000974	0.036	CbGeAlD
Carbamazepine—UGT2B7—digestive system—colon cancer	0.000866	0.032	CbGeAlD
Carbamazepine—RALBP1—digestive system—colon cancer	0.000866	0.032	CbGeAlD
Carbamazepine—RALBP1—bone marrow—colon cancer	0.000798	0.0295	CbGeAlD
Carbamazepine—RALBP1—vagina—colon cancer	0.000765	0.0283	CbGeAlD
Carbamazepine—CYP3A7—liver—colon cancer	0.000666	0.0246	CbGeAlD
Carbamazepine—RALBP1—liver—colon cancer	0.000645	0.0239	CbGeAlD
Carbamazepine—UGT2B7—liver—colon cancer	0.000645	0.0239	CbGeAlD
Carbamazepine—SCN5A—digestive system—colon cancer	0.000619	0.0229	CbGeAlD
Carbamazepine—ABCC2—renal system—colon cancer	0.000566	0.0209	CbGeAlD
Carbamazepine—CYP3A7-CYP3A51P—liver—colon cancer	0.000566	0.0209	CbGeAlD
Carbamazepine—SCN5A—vagina—colon cancer	0.000547	0.0202	CbGeAlD
Carbamazepine—SCN9A—lymph node—colon cancer	0.000511	0.0189	CbGeAlD
Carbamazepine—RALBP1—lymph node—colon cancer	0.000495	0.0183	CbGeAlD
Carbamazepine—ABCC2—digestive system—colon cancer	0.000465	0.0172	CbGeAlD
Carbamazepine—ABCB1—blood vessel—colon cancer	0.000451	0.0167	CbGeAlD
Carbamazepine—Nepafenac—PTGS2—colon cancer	0.000425	0.163	CrCbGaD
Carbamazepine—CYP2C8—renal system—colon cancer	0.000425	0.0157	CbGeAlD
Carbamazepine—Magnesium salicylate—PTGS2—colon cancer	0.000416	0.159	CrCbGaD
Carbamazepine—CYP2C19—digestive system—colon cancer	0.000399	0.0148	CbGeAlD
Carbamazepine—CYP1A2—renal system—colon cancer	0.000398	0.0147	CbGeAlD
Carbamazepine—CYP3A5—renal system—colon cancer	0.000383	0.0142	CbGeAlD
Carbamazepine—CYP2B6—renal system—colon cancer	0.000381	0.0141	CbGeAlD
Carbamazepine—Salsalate—PTGS2—colon cancer	0.000353	0.135	CrCbGaD
Carbamazepine—Oxaprozin—PTGS2—colon cancer	0.000353	0.135	CrCbGaD
Carbamazepine—CYP2C19—vagina—colon cancer	0.000353	0.013	CbGeAlD
Carbamazepine—ABCC2—liver—colon cancer	0.000346	0.0128	CbGeAlD
Carbamazepine—CYP1A2—digestive system—colon cancer	0.000326	0.0121	CbGeAlD
Carbamazepine—CYP2B6—lymphoid tissue—colon cancer	0.000316	0.0117	CbGeAlD
Carbamazepine—CYP3A5—digestive system—colon cancer	0.000314	0.0116	CbGeAlD
Carbamazepine—CYP2B6—digestive system—colon cancer	0.000313	0.0116	CbGeAlD
Carbamazepine—CYP2C9—digestive system—colon cancer	0.000309	0.0114	CbGeAlD
Carbamazepine—CYP2C8—vagina—colon cancer	0.000308	0.0114	CbGeAlD
Carbamazepine—Protriptyline—ABCB1—colon cancer	0.000305	0.117	CrCbGaD
Carbamazepine—CYP2C19—liver—colon cancer	0.000297	0.011	CbGeAlD
Carbamazepine—CYP3A4—renal system—colon cancer	0.000288	0.0106	CbGeAlD
Carbamazepine—CYP3A5—vagina—colon cancer	0.000278	0.0103	CbGeAlD
Carbamazepine—CYP2B6—vagina—colon cancer	0.000276	0.0102	CbGeAlD
Carbamazepine—ABCB1—embryo—colon cancer	0.000269	0.00995	CbGeAlD
Carbamazepine—ABCC2—lymph node—colon cancer	0.000265	0.00981	CbGeAlD
Carbamazepine—CYP2C8—liver—colon cancer	0.00026	0.0096	CbGeAlD
Carbamazepine—CYP1A2—liver—colon cancer	0.000243	0.00898	CbGeAlD
Carbamazepine—CYP3A4—digestive system—colon cancer	0.000236	0.00873	CbGeAlD
Carbamazepine—CYP3A5—liver—colon cancer	0.000234	0.00866	CbGeAlD
Carbamazepine—CYP2B6—liver—colon cancer	0.000233	0.00861	CbGeAlD
Carbamazepine—CYP2C9—liver—colon cancer	0.000231	0.00853	CbGeAlD
Carbamazepine—Epinastine—ABCB1—colon cancer	0.000226	0.0866	CrCbGaD
Carbamazepine—ABCB1—epithelium—colon cancer	0.00022	0.00812	CbGeAlD
Carbamazepine—ABCB1—renal system—colon cancer	0.000204	0.00753	CbGeAlD
Carbamazepine—CYP3A4—liver—colon cancer	0.000176	0.0065	CbGeAlD
Carbamazepine—ABCB1—lymphoid tissue—colon cancer	0.000169	0.00625	CbGeAlD
Carbamazepine—Nervous system disorder—Vincristine—colon cancer	0.000168	0.00133	CcSEcCtD
Carbamazepine—Thrombocytopenia—Vincristine—colon cancer	0.000168	0.00133	CcSEcCtD
Carbamazepine—ABCB1—digestive system—colon cancer	0.000167	0.00618	CbGeAlD
Carbamazepine—Haematuria—Capecitabine—colon cancer	0.000167	0.00132	CcSEcCtD
Carbamazepine—Oedema—Irinotecan—colon cancer	0.000167	0.00132	CcSEcCtD
Carbamazepine—Anaphylactic shock—Irinotecan—colon cancer	0.000167	0.00132	CcSEcCtD
Carbamazepine—Myalgia—Fluorouracil—colon cancer	0.000167	0.00132	CcSEcCtD
Carbamazepine—Chest pain—Fluorouracil—colon cancer	0.000167	0.00132	CcSEcCtD
Carbamazepine—Infection—Irinotecan—colon cancer	0.000166	0.00131	CcSEcCtD
Carbamazepine—Hyperhidrosis—Vincristine—colon cancer	0.000165	0.00131	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Capecitabine—colon cancer	0.000165	0.00131	CcSEcCtD
Carbamazepine—Shock—Irinotecan—colon cancer	0.000164	0.0013	CcSEcCtD
Carbamazepine—Nervous system disorder—Irinotecan—colon cancer	0.000164	0.0013	CcSEcCtD
Carbamazepine—Agranulocytosis—Capecitabine—colon cancer	0.000163	0.0013	CcSEcCtD
Carbamazepine—Thrombocytopenia—Irinotecan—colon cancer	0.000163	0.0013	CcSEcCtD
Carbamazepine—Anorexia—Vincristine—colon cancer	0.000163	0.00129	CcSEcCtD
Carbamazepine—Irritability—Methotrexate—colon cancer	0.000161	0.00128	CcSEcCtD
Carbamazepine—Hyperhidrosis—Irinotecan—colon cancer	0.000161	0.00128	CcSEcCtD
Carbamazepine—Confusional state—Fluorouracil—colon cancer	0.000161	0.00128	CcSEcCtD
Carbamazepine—Hypotension—Vincristine—colon cancer	0.00016	0.00127	CcSEcCtD
Carbamazepine—Bradycardia—Capecitabine—colon cancer	0.00016	0.00127	CcSEcCtD
Carbamazepine—Anaphylactic shock—Fluorouracil—colon cancer	0.00016	0.00127	CcSEcCtD
Carbamazepine—Oedema—Fluorouracil—colon cancer	0.00016	0.00127	CcSEcCtD
Carbamazepine—Anorexia—Irinotecan—colon cancer	0.000159	0.00126	CcSEcCtD
Carbamazepine—Ataxia—Methotrexate—colon cancer	0.000159	0.00126	CcSEcCtD
Carbamazepine—Infection—Fluorouracil—colon cancer	0.000159	0.00126	CcSEcCtD
Carbamazepine—Rhinitis—Capecitabine—colon cancer	0.000157	0.00125	CcSEcCtD
Carbamazepine—Hepatitis—Capecitabine—colon cancer	0.000157	0.00125	CcSEcCtD
Carbamazepine—Nervous system disorder—Fluorouracil—colon cancer	0.000157	0.00124	CcSEcCtD
Carbamazepine—Thrombocytopenia—Fluorouracil—colon cancer	0.000156	0.00124	CcSEcCtD
Carbamazepine—Liver function test abnormal—Methotrexate—colon cancer	0.000156	0.00124	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000156	0.00124	CcSEcCtD
Carbamazepine—Pharyngitis—Capecitabine—colon cancer	0.000156	0.00124	CcSEcCtD
Carbamazepine—Tachycardia—Fluorouracil—colon cancer	0.000156	0.00124	CcSEcCtD
Carbamazepine—Hypotension—Irinotecan—colon cancer	0.000156	0.00124	CcSEcCtD
Carbamazepine—Urinary tract disorder—Capecitabine—colon cancer	0.000155	0.00123	CcSEcCtD
Carbamazepine—Insomnia—Vincristine—colon cancer	0.000155	0.00123	CcSEcCtD
Carbamazepine—Oedema peripheral—Capecitabine—colon cancer	0.000155	0.00123	CcSEcCtD
Carbamazepine—Connective tissue disorder—Capecitabine—colon cancer	0.000154	0.00122	CcSEcCtD
Carbamazepine—ABCB1—bone marrow—colon cancer	0.000154	0.00569	CbGeAlD
Carbamazepine—Urethral disorder—Capecitabine—colon cancer	0.000154	0.00122	CcSEcCtD
Carbamazepine—Paraesthesia—Vincristine—colon cancer	0.000154	0.00122	CcSEcCtD
Carbamazepine—Anorexia—Fluorouracil—colon cancer	0.000152	0.00121	CcSEcCtD
Carbamazepine—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000152	0.00121	CcSEcCtD
Carbamazepine—Insomnia—Irinotecan—colon cancer	0.000151	0.0012	CcSEcCtD
Carbamazepine—Paraesthesia—Irinotecan—colon cancer	0.00015	0.00119	CcSEcCtD
Carbamazepine—Hypotension—Fluorouracil—colon cancer	0.000149	0.00118	CcSEcCtD
Carbamazepine—Decreased appetite—Vincristine—colon cancer	0.000149	0.00118	CcSEcCtD
Carbamazepine—Dyspnoea—Irinotecan—colon cancer	0.000149	0.00118	CcSEcCtD
Carbamazepine—Erythema multiforme—Capecitabine—colon cancer	0.000149	0.00118	CcSEcCtD
Carbamazepine—Somnolence—Irinotecan—colon cancer	0.000148	0.00118	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Vincristine—colon cancer	0.000148	0.00117	CcSEcCtD
Carbamazepine—Fatigue—Vincristine—colon cancer	0.000148	0.00117	CcSEcCtD
Carbamazepine—ABCB1—vagina—colon cancer	0.000148	0.00546	CbGeAlD
Carbamazepine—Eye disorder—Capecitabine—colon cancer	0.000147	0.00116	CcSEcCtD
Carbamazepine—Dyspepsia—Irinotecan—colon cancer	0.000147	0.00116	CcSEcCtD
Carbamazepine—Tinnitus—Capecitabine—colon cancer	0.000146	0.00116	CcSEcCtD
Carbamazepine—Pain—Vincristine—colon cancer	0.000146	0.00116	CcSEcCtD
Carbamazepine—Constipation—Vincristine—colon cancer	0.000146	0.00116	CcSEcCtD
Carbamazepine—Flushing—Capecitabine—colon cancer	0.000146	0.00116	CcSEcCtD
Carbamazepine—Cardiac disorder—Capecitabine—colon cancer	0.000146	0.00116	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000145	0.00115	CcSEcCtD
Carbamazepine—Decreased appetite—Irinotecan—colon cancer	0.000145	0.00115	CcSEcCtD
Carbamazepine—Eosinophilia—Methotrexate—colon cancer	0.000145	0.00115	CcSEcCtD
Carbamazepine—Insomnia—Fluorouracil—colon cancer	0.000144	0.00115	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000144	0.00114	CcSEcCtD
Carbamazepine—Fatigue—Irinotecan—colon cancer	0.000144	0.00114	CcSEcCtD
Carbamazepine—Paraesthesia—Fluorouracil—colon cancer	0.000143	0.00114	CcSEcCtD
Carbamazepine—Pancreatitis—Methotrexate—colon cancer	0.000143	0.00114	CcSEcCtD
Carbamazepine—Constipation—Irinotecan—colon cancer	0.000143	0.00113	CcSEcCtD
Carbamazepine—Pain—Irinotecan—colon cancer	0.000143	0.00113	CcSEcCtD
Carbamazepine—Angiopathy—Capecitabine—colon cancer	0.000142	0.00113	CcSEcCtD
Carbamazepine—Dyspnoea—Fluorouracil—colon cancer	0.000142	0.00113	CcSEcCtD
Carbamazepine—Somnolence—Fluorouracil—colon cancer	0.000142	0.00113	CcSEcCtD
Carbamazepine—Immune system disorder—Capecitabine—colon cancer	0.000142	0.00113	CcSEcCtD
Carbamazepine—Mediastinal disorder—Capecitabine—colon cancer	0.000142	0.00112	CcSEcCtD
Carbamazepine—Chills—Capecitabine—colon cancer	0.000141	0.00112	CcSEcCtD
Carbamazepine—Dyspepsia—Fluorouracil—colon cancer	0.000141	0.00112	CcSEcCtD
Carbamazepine—Arrhythmia—Capecitabine—colon cancer	0.00014	0.00111	CcSEcCtD
Carbamazepine—Abdominal discomfort—Methotrexate—colon cancer	0.00014	0.00111	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Vincristine—colon cancer	0.00014	0.00111	CcSEcCtD
Carbamazepine—Decreased appetite—Fluorouracil—colon cancer	0.000139	0.0011	CcSEcCtD
Carbamazepine—Alopecia—Capecitabine—colon cancer	0.000139	0.0011	CcSEcCtD
Carbamazepine—Pancytopenia—Methotrexate—colon cancer	0.000139	0.0011	CcSEcCtD
Carbamazepine—Phenytoin—ABCB1—colon cancer	0.000138	0.0528	CrCbGaD
Carbamazepine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000138	0.00109	CcSEcCtD
Carbamazepine—Mental disorder—Capecitabine—colon cancer	0.000138	0.00109	CcSEcCtD
Carbamazepine—Feeling abnormal—Irinotecan—colon cancer	0.000137	0.00109	CcSEcCtD
Carbamazepine—Malnutrition—Capecitabine—colon cancer	0.000137	0.00108	CcSEcCtD
Carbamazepine—Erythema—Capecitabine—colon cancer	0.000137	0.00108	CcSEcCtD
Carbamazepine—Pain—Fluorouracil—colon cancer	0.000137	0.00108	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Irinotecan—colon cancer	0.000136	0.00108	CcSEcCtD
Carbamazepine—Abdominal pain—Vincristine—colon cancer	0.000135	0.00107	CcSEcCtD
Carbamazepine—Body temperature increased—Vincristine—colon cancer	0.000135	0.00107	CcSEcCtD
Carbamazepine—Erectile dysfunction—Methotrexate—colon cancer	0.000135	0.00107	CcSEcCtD
Carbamazepine—Dysgeusia—Capecitabine—colon cancer	0.000134	0.00106	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Methotrexate—colon cancer	0.000133	0.00106	CcSEcCtD
Carbamazepine—Back pain—Capecitabine—colon cancer	0.000132	0.00105	CcSEcCtD
Carbamazepine—Abdominal pain—Irinotecan—colon cancer	0.000132	0.00105	CcSEcCtD
Carbamazepine—Body temperature increased—Irinotecan—colon cancer	0.000132	0.00105	CcSEcCtD
Carbamazepine—Feeling abnormal—Fluorouracil—colon cancer	0.000132	0.00104	CcSEcCtD
Carbamazepine—Muscle spasms—Capecitabine—colon cancer	0.000131	0.00104	CcSEcCtD
Carbamazepine—Pneumonia—Methotrexate—colon cancer	0.000131	0.00104	CcSEcCtD
Carbamazepine—Infestation NOS—Methotrexate—colon cancer	0.00013	0.00103	CcSEcCtD
Carbamazepine—Infestation—Methotrexate—colon cancer	0.00013	0.00103	CcSEcCtD
Carbamazepine—Drowsiness—Methotrexate—colon cancer	0.00013	0.00103	CcSEcCtD
Carbamazepine—Depression—Methotrexate—colon cancer	0.00013	0.00103	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000129	0.00102	CcSEcCtD
Carbamazepine—Vision blurred—Capecitabine—colon cancer	0.000129	0.00102	CcSEcCtD
Carbamazepine—Tremor—Capecitabine—colon cancer	0.000128	0.00102	CcSEcCtD
Carbamazepine—Renal failure—Methotrexate—colon cancer	0.000128	0.00102	CcSEcCtD
Carbamazepine—Stomatitis—Methotrexate—colon cancer	0.000127	0.00101	CcSEcCtD
Carbamazepine—Urticaria—Fluorouracil—colon cancer	0.000127	0.00101	CcSEcCtD
Carbamazepine—Conjunctivitis—Methotrexate—colon cancer	0.000127	0.001	CcSEcCtD
Carbamazepine—Anaemia—Capecitabine—colon cancer	0.000126	0.001	CcSEcCtD
Carbamazepine—Body temperature increased—Fluorouracil—colon cancer	0.000126	0.001	CcSEcCtD
Carbamazepine—Hypersensitivity—Vincristine—colon cancer	0.000126	0.001	CcSEcCtD
Carbamazepine—ABCB1—liver—colon cancer	0.000124	0.0046	CbGeAlD
Carbamazepine—Haematuria—Methotrexate—colon cancer	0.000124	0.000985	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Methotrexate—colon cancer	0.000123	0.000977	CcSEcCtD
Carbamazepine—Vertigo—Capecitabine—colon cancer	0.000123	0.000975	CcSEcCtD
Carbamazepine—Hypersensitivity—Irinotecan—colon cancer	0.000123	0.000975	CcSEcCtD
Carbamazepine—Asthenia—Vincristine—colon cancer	0.000123	0.000974	CcSEcCtD
Carbamazepine—Syncope—Capecitabine—colon cancer	0.000123	0.000973	CcSEcCtD
Carbamazepine—Leukopenia—Capecitabine—colon cancer	0.000122	0.000971	CcSEcCtD
Carbamazepine—Agranulocytosis—Methotrexate—colon cancer	0.000122	0.000964	CcSEcCtD
Carbamazepine—Loss of consciousness—Capecitabine—colon cancer	0.00012	0.000953	CcSEcCtD
Carbamazepine—Asthenia—Irinotecan—colon cancer	0.00012	0.000949	CcSEcCtD
Carbamazepine—Hypertension—Capecitabine—colon cancer	0.000118	0.000936	CcSEcCtD
Carbamazepine—Hypersensitivity—Fluorouracil—colon cancer	0.000118	0.000933	CcSEcCtD
Carbamazepine—Diarrhoea—Vincristine—colon cancer	0.000117	0.000929	CcSEcCtD
Carbamazepine—Hepatitis—Methotrexate—colon cancer	0.000117	0.000928	CcSEcCtD
Carbamazepine—Chest pain—Capecitabine—colon cancer	0.000116	0.000923	CcSEcCtD
Carbamazepine—Myalgia—Capecitabine—colon cancer	0.000116	0.000923	CcSEcCtD
Carbamazepine—Arthralgia—Capecitabine—colon cancer	0.000116	0.000923	CcSEcCtD
Carbamazepine—Pharyngitis—Methotrexate—colon cancer	0.000116	0.000921	CcSEcCtD
Carbamazepine—Anxiety—Capecitabine—colon cancer	0.000116	0.00092	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000116	0.000917	CcSEcCtD
Carbamazepine—Urinary tract disorder—Methotrexate—colon cancer	0.000115	0.000916	CcSEcCtD
Carbamazepine—Urethral disorder—Methotrexate—colon cancer	0.000115	0.000909	CcSEcCtD
Carbamazepine—Diarrhoea—Irinotecan—colon cancer	0.000114	0.000905	CcSEcCtD
Carbamazepine—Dry mouth—Capecitabine—colon cancer	0.000114	0.000903	CcSEcCtD
Carbamazepine—Dizziness—Vincristine—colon cancer	0.000113	0.000898	CcSEcCtD
Carbamazepine—Pruritus—Fluorouracil—colon cancer	0.000113	0.000896	CcSEcCtD
Carbamazepine—Confusional state—Capecitabine—colon cancer	0.000113	0.000893	CcSEcCtD
Carbamazepine—Oedema—Capecitabine—colon cancer	0.000112	0.000885	CcSEcCtD
Carbamazepine—Infection—Capecitabine—colon cancer	0.000111	0.000879	CcSEcCtD
Carbamazepine—Erythema multiforme—Methotrexate—colon cancer	0.000111	0.000877	CcSEcCtD
Carbamazepine—Dizziness—Irinotecan—colon cancer	0.00011	0.000875	CcSEcCtD
Carbamazepine—Trimipramine—ABCB1—colon cancer	0.00011	0.0422	CrCbGaD
Carbamazepine—Shock—Capecitabine—colon cancer	0.00011	0.000871	CcSEcCtD
Carbamazepine—Nervous system disorder—Capecitabine—colon cancer	0.000109	0.000868	CcSEcCtD
Carbamazepine—Eye disorder—Methotrexate—colon cancer	0.000109	0.000867	CcSEcCtD
Carbamazepine—Diarrhoea—Fluorouracil—colon cancer	0.000109	0.000867	CcSEcCtD
Carbamazepine—Thrombocytopenia—Capecitabine—colon cancer	0.000109	0.000867	CcSEcCtD
Carbamazepine—Tinnitus—Methotrexate—colon cancer	0.000109	0.000865	CcSEcCtD
Carbamazepine—Tachycardia—Capecitabine—colon cancer	0.000109	0.000864	CcSEcCtD
Carbamazepine—Vomiting—Vincristine—colon cancer	0.000109	0.000864	CcSEcCtD
Carbamazepine—Cardiac disorder—Methotrexate—colon cancer	0.000109	0.000861	CcSEcCtD
Carbamazepine—Skin disorder—Capecitabine—colon cancer	0.000108	0.00086	CcSEcCtD
Carbamazepine—Rash—Vincristine—colon cancer	0.000108	0.000856	CcSEcCtD
Carbamazepine—Hyperhidrosis—Capecitabine—colon cancer	0.000108	0.000856	CcSEcCtD
Carbamazepine—Dermatitis—Vincristine—colon cancer	0.000108	0.000856	CcSEcCtD
Carbamazepine—Headache—Vincristine—colon cancer	0.000107	0.000851	CcSEcCtD
Carbamazepine—Anorexia—Capecitabine—colon cancer	0.000106	0.000844	CcSEcCtD
Carbamazepine—Angiopathy—Methotrexate—colon cancer	0.000106	0.000842	CcSEcCtD
Carbamazepine—Promethazine—ABCB1—colon cancer	0.000106	0.0406	CrCbGaD
Carbamazepine—Vomiting—Irinotecan—colon cancer	0.000106	0.000841	CcSEcCtD
Carbamazepine—Immune system disorder—Methotrexate—colon cancer	0.000106	0.000838	CcSEcCtD
Carbamazepine—Dizziness—Fluorouracil—colon cancer	0.000106	0.000838	CcSEcCtD
Carbamazepine—Mediastinal disorder—Methotrexate—colon cancer	0.000105	0.000836	CcSEcCtD
Carbamazepine—Rash—Irinotecan—colon cancer	0.000105	0.000834	CcSEcCtD
Carbamazepine—Dermatitis—Irinotecan—colon cancer	0.000105	0.000833	CcSEcCtD
Carbamazepine—Chills—Methotrexate—colon cancer	0.000105	0.000832	CcSEcCtD
Carbamazepine—Headache—Irinotecan—colon cancer	0.000104	0.000829	CcSEcCtD
Carbamazepine—Hypotension—Capecitabine—colon cancer	0.000104	0.000827	CcSEcCtD
Carbamazepine—Alopecia—Methotrexate—colon cancer	0.000103	0.00082	CcSEcCtD
Carbamazepine—Mental disorder—Methotrexate—colon cancer	0.000102	0.000813	CcSEcCtD
Carbamazepine—Erythema—Methotrexate—colon cancer	0.000102	0.000807	CcSEcCtD
Carbamazepine—Malnutrition—Methotrexate—colon cancer	0.000102	0.000807	CcSEcCtD
Carbamazepine—Nausea—Vincristine—colon cancer	0.000102	0.000807	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000102	0.000807	CcSEcCtD
Carbamazepine—Vomiting—Fluorouracil—colon cancer	0.000102	0.000805	CcSEcCtD
Carbamazepine—Insomnia—Capecitabine—colon cancer	0.000101	0.000801	CcSEcCtD
Carbamazepine—Rash—Fluorouracil—colon cancer	0.000101	0.000799	CcSEcCtD
Carbamazepine—Dermatitis—Fluorouracil—colon cancer	0.000101	0.000798	CcSEcCtD
Carbamazepine—Paraesthesia—Capecitabine—colon cancer	0.0001	0.000795	CcSEcCtD
Carbamazepine—Headache—Fluorouracil—colon cancer	0.0001	0.000794	CcSEcCtD
Carbamazepine—Dysgeusia—Methotrexate—colon cancer	9.97e-05	0.000791	CcSEcCtD
Carbamazepine—Dyspnoea—Capecitabine—colon cancer	9.95e-05	0.000789	CcSEcCtD
Carbamazepine—Nausea—Irinotecan—colon cancer	9.9e-05	0.000786	CcSEcCtD
Carbamazepine—Back pain—Methotrexate—colon cancer	9.85e-05	0.000781	CcSEcCtD
Carbamazepine—Dyspepsia—Capecitabine—colon cancer	9.82e-05	0.000779	CcSEcCtD
Carbamazepine—Decreased appetite—Capecitabine—colon cancer	9.7e-05	0.00077	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Capecitabine—colon cancer	9.63e-05	0.000764	CcSEcCtD
Carbamazepine—Desipramine—ABCB1—colon cancer	9.63e-05	0.0369	CrCbGaD
Carbamazepine—Fatigue—Capecitabine—colon cancer	9.62e-05	0.000763	CcSEcCtD
Carbamazepine—Vision blurred—Methotrexate—colon cancer	9.59e-05	0.000761	CcSEcCtD
Carbamazepine—Pain—Capecitabine—colon cancer	9.54e-05	0.000757	CcSEcCtD
Carbamazepine—Constipation—Capecitabine—colon cancer	9.54e-05	0.000757	CcSEcCtD
Carbamazepine—ABCB1—lymph node—colon cancer	9.54e-05	0.00353	CbGeAlD
Carbamazepine—Nausea—Fluorouracil—colon cancer	9.48e-05	0.000752	CcSEcCtD
Carbamazepine—Anaemia—Methotrexate—colon cancer	9.41e-05	0.000746	CcSEcCtD
Carbamazepine—Feeling abnormal—Capecitabine—colon cancer	9.2e-05	0.000729	CcSEcCtD
Carbamazepine—Vertigo—Methotrexate—colon cancer	9.14e-05	0.000725	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Capecitabine—colon cancer	9.12e-05	0.000724	CcSEcCtD
Carbamazepine—Leukopenia—Methotrexate—colon cancer	9.11e-05	0.000723	CcSEcCtD
Carbamazepine—Urticaria—Capecitabine—colon cancer	8.86e-05	0.000703	CcSEcCtD
Carbamazepine—Body temperature increased—Capecitabine—colon cancer	8.82e-05	0.0007	CcSEcCtD
Carbamazepine—Abdominal pain—Capecitabine—colon cancer	8.82e-05	0.0007	CcSEcCtD
Carbamazepine—Convulsion—Methotrexate—colon cancer	8.82e-05	0.0007	CcSEcCtD
Carbamazepine—Myalgia—Methotrexate—colon cancer	8.67e-05	0.000687	CcSEcCtD
Carbamazepine—Arthralgia—Methotrexate—colon cancer	8.67e-05	0.000687	CcSEcCtD
Carbamazepine—Chest pain—Methotrexate—colon cancer	8.67e-05	0.000687	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	8.61e-05	0.000683	CcSEcCtD
Carbamazepine—Confusional state—Methotrexate—colon cancer	8.38e-05	0.000664	CcSEcCtD
Carbamazepine—Anaphylactic shock—Methotrexate—colon cancer	8.31e-05	0.000659	CcSEcCtD
Carbamazepine—Infection—Methotrexate—colon cancer	8.25e-05	0.000655	CcSEcCtD
Carbamazepine—Hypersensitivity—Capecitabine—colon cancer	8.22e-05	0.000652	CcSEcCtD
Carbamazepine—Imipramine—ABCB1—colon cancer	8.17e-05	0.0313	CrCbGaD
Carbamazepine—Nervous system disorder—Methotrexate—colon cancer	8.15e-05	0.000646	CcSEcCtD
Carbamazepine—Thrombocytopenia—Methotrexate—colon cancer	8.13e-05	0.000645	CcSEcCtD
Carbamazepine—Skin disorder—Methotrexate—colon cancer	8.07e-05	0.00064	CcSEcCtD
Carbamazepine—Hyperhidrosis—Methotrexate—colon cancer	8.03e-05	0.000637	CcSEcCtD
Carbamazepine—Asthenia—Capecitabine—colon cancer	8.01e-05	0.000635	CcSEcCtD
Carbamazepine—Anorexia—Methotrexate—colon cancer	7.92e-05	0.000628	CcSEcCtD
Carbamazepine—Pruritus—Capecitabine—colon cancer	7.89e-05	0.000626	CcSEcCtD
Carbamazepine—Hypotension—Methotrexate—colon cancer	7.76e-05	0.000616	CcSEcCtD
Carbamazepine—Diarrhoea—Capecitabine—colon cancer	7.63e-05	0.000606	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Methotrexate—colon cancer	7.57e-05	0.0006	CcSEcCtD
Carbamazepine—Insomnia—Methotrexate—colon cancer	7.51e-05	0.000596	CcSEcCtD
Carbamazepine—Paraesthesia—Methotrexate—colon cancer	7.46e-05	0.000592	CcSEcCtD
Carbamazepine—Dyspnoea—Methotrexate—colon cancer	7.41e-05	0.000588	CcSEcCtD
Carbamazepine—Somnolence—Methotrexate—colon cancer	7.38e-05	0.000586	CcSEcCtD
Carbamazepine—Dizziness—Capecitabine—colon cancer	7.38e-05	0.000585	CcSEcCtD
Carbamazepine—Dyspepsia—Methotrexate—colon cancer	7.31e-05	0.00058	CcSEcCtD
Carbamazepine—Decreased appetite—Methotrexate—colon cancer	7.22e-05	0.000573	CcSEcCtD
Carbamazepine—SCN5A—Developmental Biology—DCC—colon cancer	7.22e-05	0.00334	CbGpPWpGaD
Carbamazepine—Gastrointestinal disorder—Methotrexate—colon cancer	7.17e-05	0.000569	CcSEcCtD
Carbamazepine—Fatigue—Methotrexate—colon cancer	7.16e-05	0.000568	CcSEcCtD
Carbamazepine—Pain—Methotrexate—colon cancer	7.1e-05	0.000564	CcSEcCtD
Carbamazepine—Vomiting—Capecitabine—colon cancer	7.09e-05	0.000563	CcSEcCtD
Carbamazepine—Rash—Capecitabine—colon cancer	7.04e-05	0.000558	CcSEcCtD
Carbamazepine—Dermatitis—Capecitabine—colon cancer	7.03e-05	0.000558	CcSEcCtD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—HRAS—colon cancer	7.02e-05	0.00325	CbGpPWpGaD
Carbamazepine—Headache—Capecitabine—colon cancer	6.99e-05	0.000555	CcSEcCtD
Carbamazepine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	6.93e-05	0.00321	CbGpPWpGaD
Carbamazepine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	6.89e-05	0.00319	CbGpPWpGaD
Carbamazepine—Feeling abnormal—Methotrexate—colon cancer	6.85e-05	0.000543	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Methotrexate—colon cancer	6.79e-05	0.000539	CcSEcCtD
Carbamazepine—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	6.7e-05	0.0031	CbGpPWpGaD
Carbamazepine—Nausea—Capecitabine—colon cancer	6.63e-05	0.000526	CcSEcCtD
Carbamazepine—Urticaria—Methotrexate—colon cancer	6.6e-05	0.000524	CcSEcCtD
Carbamazepine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	6.57e-05	0.00304	CbGpPWpGaD
Carbamazepine—Abdominal pain—Methotrexate—colon cancer	6.57e-05	0.000521	CcSEcCtD
Carbamazepine—Body temperature increased—Methotrexate—colon cancer	6.57e-05	0.000521	CcSEcCtD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	6.32e-05	0.00293	CbGpPWpGaD
Carbamazepine—SCN5A—L1CAM interactions—SRC—colon cancer	6.22e-05	0.00288	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—AKT1—colon cancer	6.2e-05	0.00287	CbGpPWpGaD
Carbamazepine—Hypersensitivity—Methotrexate—colon cancer	6.12e-05	0.000486	CcSEcCtD
Carbamazepine—SCN5A—Developmental Biology—HNF4A—colon cancer	6.07e-05	0.00281	CbGpPWpGaD
Carbamazepine—Asthenia—Methotrexate—colon cancer	5.96e-05	0.000473	CcSEcCtD
Carbamazepine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	5.92e-05	0.00274	CbGpPWpGaD
Carbamazepine—Pruritus—Methotrexate—colon cancer	5.88e-05	0.000466	CcSEcCtD
Carbamazepine—CYP3A7—Metabolism—CA7—colon cancer	5.71e-05	0.00264	CbGpPWpGaD
Carbamazepine—Diarrhoea—Methotrexate—colon cancer	5.68e-05	0.000451	CcSEcCtD
Carbamazepine—Dizziness—Methotrexate—colon cancer	5.49e-05	0.000436	CcSEcCtD
Carbamazepine—SCN5A—L1CAM interactions—EGFR—colon cancer	5.45e-05	0.00253	CbGpPWpGaD
Carbamazepine—Vomiting—Methotrexate—colon cancer	5.28e-05	0.000419	CcSEcCtD
Carbamazepine—Rash—Methotrexate—colon cancer	5.24e-05	0.000416	CcSEcCtD
Carbamazepine—Dermatitis—Methotrexate—colon cancer	5.23e-05	0.000415	CcSEcCtD
Carbamazepine—Headache—Methotrexate—colon cancer	5.2e-05	0.000413	CcSEcCtD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	5.1e-05	0.00236	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—ODC1—colon cancer	5.06e-05	0.00234	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—CHST5—colon cancer	5.06e-05	0.00234	CbGpPWpGaD
Carbamazepine—Nausea—Methotrexate—colon cancer	4.93e-05	0.000391	CcSEcCtD
Carbamazepine—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	4.92e-05	0.00228	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—CASP3—colon cancer	4.84e-05	0.00224	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—colon cancer	4.67e-05	0.00216	CbGpPWpGaD
Carbamazepine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.57e-05	0.00212	CbGpPWpGaD
Carbamazepine—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	4.39e-05	0.00203	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—EP300—colon cancer	4.34e-05	0.00201	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	4.29e-05	0.00199	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—PPARG—colon cancer	4.23e-05	0.00196	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CA7—colon cancer	4.22e-05	0.00195	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CA7—colon cancer	4.12e-05	0.00191	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—VEGFA—colon cancer	4.11e-05	0.0019	CbGpPWpGaD
Carbamazepine—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	4e-05	0.00185	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—PPARG—colon cancer	3.89e-05	0.0018	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—SRC—colon cancer	3.77e-05	0.00175	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—VEGFA—colon cancer	3.68e-05	0.0017	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	3.66e-05	0.00169	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—NRAS—colon cancer	3.63e-05	0.00168	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CA7—colon cancer	3.57e-05	0.00165	CbGpPWpGaD
Carbamazepine—UGT2B7—NRF2 pathway—TGFB1—colon cancer	3.53e-05	0.00163	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—SRC—colon cancer	3.47e-05	0.00161	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CHST5—colon cancer	3.46e-05	0.0016	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ODC1—colon cancer	3.46e-05	0.0016	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	3.43e-05	0.00159	CbGpPWpGaD
Carbamazepine—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	3.42e-05	0.00158	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—VEGFA—colon cancer	3.38e-05	0.00156	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—NRAS—colon cancer	3.34e-05	0.00155	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—EGFR—colon cancer	3.31e-05	0.00153	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	3.2e-05	0.00148	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CA7—colon cancer	3.19e-05	0.00148	CbGpPWpGaD
Carbamazepine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	3.16e-05	0.00146	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—KRAS—colon cancer	3.13e-05	0.00145	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CA7—colon cancer	3.11e-05	0.00144	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	3.04e-05	0.00141	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	3.04e-05	0.00141	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—EGFR—colon cancer	3.04e-05	0.00141	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—CTNNB1—colon cancer	2.98e-05	0.00138	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	2.96e-05	0.00137	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	2.96e-05	0.00137	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CA7—colon cancer	2.91e-05	0.00135	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	2.88e-05	0.00133	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—KRAS—colon cancer	2.87e-05	0.00133	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	2.85e-05	0.00132	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	2.85e-05	0.00132	CbGpPWpGaD
Carbamazepine—ABCC2—NRF2 pathway—TGFB1—colon cancer	2.8e-05	0.00129	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—EP300—colon cancer	2.77e-05	0.00128	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—CASP3—colon cancer	2.76e-05	0.00128	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—CTNNB1—colon cancer	2.74e-05	0.00127	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	2.7e-05	0.00125	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—SRC—colon cancer	2.69e-05	0.00125	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—HRAS—colon cancer	2.66e-05	0.00123	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	2.65e-05	0.00123	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	2.64e-05	0.00122	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—PPARG—colon cancer	2.64e-05	0.00122	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	2.63e-05	0.00122	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—VEGFA—colon cancer	2.62e-05	0.00121	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	2.59e-05	0.0012	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	2.59e-05	0.0012	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—NRAS—colon cancer	2.59e-05	0.0012	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CHST5—colon cancer	2.56e-05	0.00118	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ODC1—colon cancer	2.56e-05	0.00118	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—EP300—colon cancer	2.55e-05	0.00118	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	2.54e-05	0.00117	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ODC1—colon cancer	2.5e-05	0.00116	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CHST5—colon cancer	2.5e-05	0.00116	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CA7—colon cancer	2.48e-05	0.00115	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—SRC—colon cancer	2.48e-05	0.00115	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	2.45e-05	0.00113	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—HRAS—colon cancer	2.44e-05	0.00113	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—VEGFA—colon cancer	2.41e-05	0.00112	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—FGFR3—colon cancer	2.41e-05	0.00112	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—TGFB1—colon cancer	2.41e-05	0.00112	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—NRAS—colon cancer	2.38e-05	0.0011	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—EGFR—colon cancer	2.36e-05	0.00109	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—SRC—colon cancer	2.35e-05	0.00109	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—VEGFA—colon cancer	2.34e-05	0.00108	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—VEGFA—colon cancer	2.29e-05	0.00106	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.26e-05	0.00105	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—NRAS—colon cancer	2.26e-05	0.00105	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—KRAS—colon cancer	2.23e-05	0.00103	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—APC—colon cancer	2.21e-05	0.00102	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—TGFB1—colon cancer	2.21e-05	0.00102	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—EGFR—colon cancer	2.17e-05	0.001	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CHST5—colon cancer	2.16e-05	0.001	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ODC1—colon cancer	2.16e-05	0.001	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—TGFB1—colon cancer	2.15e-05	0.000995	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	2.08e-05	0.000964	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—BRAF—colon cancer	2.08e-05	0.000963	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—EGFR—colon cancer	2.06e-05	0.000954	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—KRAS—colon cancer	2.05e-05	0.000949	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—KRAS—colon cancer	1.95e-05	0.000902	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ODC1—colon cancer	1.93e-05	0.000895	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CHST5—colon cancer	1.93e-05	0.000895	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.93e-05	0.000894	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CA7—colon cancer	1.92e-05	0.000888	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—HRAS—colon cancer	1.9e-05	0.000878	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CHST5—colon cancer	1.89e-05	0.000873	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ODC1—colon cancer	1.89e-05	0.000873	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—CTNNB1—colon cancer	1.86e-05	0.00086	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CHST5—colon cancer	1.76e-05	0.000816	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ODC1—colon cancer	1.76e-05	0.000816	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—HRAS—colon cancer	1.74e-05	0.000807	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—EP300—colon cancer	1.73e-05	0.000799	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.72e-05	0.000799	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—SRC—colon cancer	1.68e-05	0.000777	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—AKT1—colon cancer	1.67e-05	0.000775	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—HRAS—colon cancer	1.66e-05	0.000766	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—VEGFA—colon cancer	1.63e-05	0.000757	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—NRAS—colon cancer	1.61e-05	0.000748	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CASP3—colon cancer	1.56e-05	0.000722	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—AKT1—colon cancer	1.54e-05	0.000712	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CCND1—colon cancer	1.52e-05	0.000703	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ODC1—colon cancer	1.51e-05	0.000697	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CHST5—colon cancer	1.51e-05	0.000697	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CTNNB1—colon cancer	1.5e-05	0.000696	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—TGFB1—colon cancer	1.5e-05	0.000695	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—EGFR—colon cancer	1.47e-05	0.000681	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CDKN1A—colon cancer	1.47e-05	0.00068	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.47e-05	0.000679	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—EP300—colon cancer	1.4e-05	0.000647	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—KRAS—colon cancer	1.39e-05	0.000643	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.36e-05	0.00063	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—SRC—colon cancer	1.36e-05	0.000629	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—ABCB1—colon cancer	1.34e-05	0.000619	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.33e-05	0.000614	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—VEGFA—colon cancer	1.32e-05	0.000613	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—TYMS—colon cancer	1.31e-05	0.000608	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.31e-05	0.000608	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—NRAS—colon cancer	1.31e-05	0.000605	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.28e-05	0.000594	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.22e-05	0.000565	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MYC—colon cancer	1.22e-05	0.000564	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TGFB1—colon cancer	1.21e-05	0.000562	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—EGFR—colon cancer	1.19e-05	0.000551	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.19e-05	0.000549	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—HRAS—colon cancer	1.18e-05	0.000547	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CHST5—colon cancer	1.16e-05	0.000538	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ODC1—colon cancer	1.16e-05	0.000538	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.16e-05	0.000535	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—KRAS—colon cancer	1.13e-05	0.000521	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.06e-05	0.000492	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.06e-05	0.000491	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—AKT1—colon cancer	1.04e-05	0.000483	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.04e-05	0.000481	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PIK3CA—colon cancer	1.03e-05	0.000479	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TP53—colon cancer	1e-05	0.000463	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	9.82e-06	0.000455	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—HRAS—colon cancer	9.56e-06	0.000443	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PPARG—colon cancer	9.3e-06	0.000431	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ABCB1—colon cancer	9.14e-06	0.000423	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	9.02e-06	0.000418	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—TYMS—colon cancer	8.97e-06	0.000415	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.94e-06	0.000414	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	8.73e-06	0.000404	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—AKT1—colon cancer	8.44e-06	0.000391	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.98e-06	0.000369	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	7.37e-06	0.000341	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTGS2—colon cancer	7.32e-06	0.000339	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.27e-06	0.000337	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.03e-06	0.000325	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ABCB1—colon cancer	6.76e-06	0.000313	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—TYMS—colon cancer	6.64e-06	0.000307	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ABCB1—colon cancer	6.6e-06	0.000306	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—TYMS—colon cancer	6.49e-06	0.0003	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PPARG—colon cancer	6.36e-06	0.000294	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.27e-06	0.000291	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.21e-06	0.000288	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—EP300—colon cancer	6.08e-06	0.000282	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.85e-06	0.000271	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.72e-06	0.000265	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ABCB1—colon cancer	5.72e-06	0.000265	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—TYMS—colon cancer	5.62e-06	0.00026	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.22e-06	0.000242	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ABCB1—colon cancer	5.11e-06	0.000236	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—TYMS—colon cancer	5.01e-06	0.000232	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTGS2—colon cancer	5e-06	0.000232	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—TYMS—colon cancer	4.89e-06	0.000227	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.89e-06	0.000226	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.76e-06	0.00022	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PPARG—colon cancer	4.7e-06	0.000218	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ABCB1—colon cancer	4.66e-06	0.000216	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PPARG—colon cancer	4.59e-06	0.000213	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—TYMS—colon cancer	4.57e-06	0.000212	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CA—colon cancer	4.5e-06	0.000208	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.32e-06	0.0002	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—EP300—colon cancer	4.16e-06	0.000193	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.07e-06	0.000188	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PPARG—colon cancer	3.98e-06	0.000184	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ABCB1—colon cancer	3.98e-06	0.000184	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—TYMS—colon cancer	3.91e-06	0.000181	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.86e-06	0.000179	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTGS2—colon cancer	3.7e-06	0.000171	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—AKT1—colon cancer	3.68e-06	0.00017	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTGS2—colon cancer	3.61e-06	0.000167	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PPARG—colon cancer	3.55e-06	0.000164	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.52e-06	0.000163	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PPARG—colon cancer	3.47e-06	0.000161	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PPARG—colon cancer	3.24e-06	0.00015	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTGS2—colon cancer	3.13e-06	0.000145	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CA—colon cancer	3.08e-06	0.000142	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—EP300—colon cancer	3.08e-06	0.000142	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ABCB1—colon cancer	3.07e-06	0.000142	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—TYMS—colon cancer	3.02e-06	0.00014	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.01e-06	0.000139	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—EP300—colon cancer	3.01e-06	0.000139	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTGS2—colon cancer	2.79e-06	0.000129	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PPARG—colon cancer	2.77e-06	0.000128	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTGS2—colon cancer	2.73e-06	0.000126	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—EP300—colon cancer	2.6e-06	0.000121	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTGS2—colon cancer	2.55e-06	0.000118	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—AKT1—colon cancer	2.51e-06	0.000116	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—EP300—colon cancer	2.32e-06	0.000108	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CA—colon cancer	2.27e-06	0.000105	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—EP300—colon cancer	2.27e-06	0.000105	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CA—colon cancer	2.22e-06	0.000103	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTGS2—colon cancer	2.18e-06	0.000101	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PPARG—colon cancer	2.14e-06	9.89e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—EP300—colon cancer	2.12e-06	9.81e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CA—colon cancer	1.93e-06	8.92e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—AKT1—colon cancer	1.86e-06	8.61e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—AKT1—colon cancer	1.82e-06	8.41e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—EP300—colon cancer	1.81e-06	8.38e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CA—colon cancer	1.72e-06	7.96e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTGS2—colon cancer	1.68e-06	7.78e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CA—colon cancer	1.68e-06	7.77e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—AKT1—colon cancer	1.57e-06	7.29e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CA—colon cancer	1.57e-06	7.26e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—AKT1—colon cancer	1.4e-06	6.5e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—EP300—colon cancer	1.4e-06	6.47e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—AKT1—colon cancer	1.37e-06	6.35e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CA—colon cancer	1.34e-06	6.2e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—AKT1—colon cancer	1.28e-06	5.93e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—AKT1—colon cancer	1.09e-06	5.07e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CA—colon cancer	1.03e-06	4.79e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—AKT1—colon cancer	8.45e-07	3.91e-05	CbGpPWpGaD
